Brit Fitzner
Rostock, MV, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators.
Journal: Frontiers in immunology
Published: November 20, 2024
Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapse.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 05, 2024
The Utility of Miniaturized Adsorbers in Exploring the Cellular and Molecular Effects of Blood Purification: A Pilot Study with a Focus on Immunoadsorption in Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: December 22, 2023
Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy.
Journal: Journal of neuroinflammation
Published: October 12, 2022
Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing.
Journal: Frontiers in immunology
Published: April 29, 2022
Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis.
Journal: Biomolecules
Published: July 02, 2021
Principles and Practical Considerations for the Analysis of Disease-Associated Alternative Splicing Events Using the Gateway Cloning-Based Minigene Vectors pDESTsplice and pSpliceExpress.
Journal: International journal of molecular sciences
Published: March 31, 2021
Leukocyte Telomere Length in Patients with Multiple Sclerosis and Its Association with Clinical Phenotypes.
Journal: Molecular neurobiology
Published: December 09, 2020
Systematic Review of Studies on Telomere Length in Patients with Multiple Sclerosis.
Journal: Aging and disease
Published: November 24, 2020
Reduced Fragmentation of IGFBP-2 and IGFBP-3 as a Potential Mechanism for Decreased Ratio of IGF-II to IGFBPs in Cerebrospinal Fluid in Response to Repeated Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis.
Journal: Frontiers in endocrinology
Published: May 25, 2020
Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis.
Journal: Frontiers in endocrinology
Published: April 20, 2020
Last Updated: 09/26/2026